Amplia (ASX:ATX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Amplia.
RELATED STOCKHEAD STORIES
ASX June Health Winners: Sector falls 1.05pc but Amplia up 300pc after positive trial news
ASX June Winners: ASX 200 rose 1.4pc in June, up nearly 10pc for quarter
Health Check: And the EOFY biotech winner is … gasp … a pot stock
Health Check: Inoviq cops ASX ‘speeding ticket’ query over cancer study headline claims
Lunch Wrap: ASX swings flat as iron ore drags and energy stocks sink
Closing Bell: ASX bets on July rate cut as employment data lands
Health Check: On Garfield the Cat Day, the biotech sector purrs with deals and breakthroughs
Top 10 at 11: ASX dips in early trade; Amplia achieves second pancreatic cancer complete response
Health Check: A pancreatic cancer ‘cure’ has been elusive, but Amplia may have cracked the nut
Top 10 at 11: ASX climbs as energy stocks rocket higher
Rise and Shine: Everything you need to know before the ASX opens
Dr Boreham’s Crucible: This pancreatic cancer tackler has faith its ‘good science will prevail’
Closing Bell: ASX shakes off morning malaise; Xero jumps on profit and revenue gains
